Log In
person
ANI Pharmaceuticals Inc
ANIP
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Generics, Established Brands, and Other |
Generic Pharmaceuticals
These companies manufacture generic drugs.
|
269.45M | 55.35% |
| Generics, Established Brands, and Other |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
105.25M | 21.62% |
| Rare Disease Segment |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
112.12M | 23.03% |
| keyboard_arrow_down |
Generics, Established Brands, and Other
Generic Pharmaceuticals
|
269.45M | 55.35% |
| keyboard_arrow_right |
These companies manufacture generic drugs.
|
||
| keyboard_arrow_down |
Generics, Established Brands, and Other
Branded Pharmaceuticals
|
105.25M | 21.62% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Rare Disease Segment
Branded Pharmaceuticals
|
112.12M | 23.03% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||